China speeds up clinical trials for Covid-19 cure


WUHAN (China Daily/ANN): With the public eagerly anticipating effective drugs to cure the novel coronavirus pneumonia, a medical ethics committee at the forefront of fighting the outbreak in Wuhan has quickened the pace of approving clinical trials.

Several programmes related to the diagnosis and treatment of the disease have gained ethical approval from Huazhong University of Science and Technology and are being carried out by the university, including two drugs that are under clinical trials, said Chen Jianguo, vice-president of the university.

Get 30% off with our ads free Premium Plan!

Monthly Plan

RM13.90/month
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

china , clinical , trials , Wuhan , covid-19 , drugs

   

Next In Regional

Acting legend Tony Leung, Nvidia chief Huang get honorary doctorates from HK uni
India reports 'good progress' in Asean-India trade pact review talks
KL in 50th spot as London crowned world's best city for 10th consecutive year
Malaysia commends Laos for successful Asean 2024 chairmanship
Supply chain snags: Airlines in Malaysia, Thailand among those affected as travel demand rebounds
41 passengers injured as Hong Kong ferry bumps into pier on Central’s waterfront
DPM Zahid emphasises shared goals in meeting with Philippines President Marcos
Malaysia’s strategies as Asean chair in 2025 focus on regional value chains, says Anwar
Asean Foreign Ministers' meeting kicks off in Laos ahead of 44th and 45th Asean Summits
Asean must remain neutral to boost regional investment, says Tengku Zafrul

Others Also Read